Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study is aimed to evaluate the clinical outcomes, efficiency and feasibility of the real-time heart team approach and the conventional heart team approach.
This study is a multicenter, randomized controlled trial. According to the inclusion and exclusion criteria, patients with complex coronary artery disease undergoing elective coronary angiography will be prospectively enrolled in the study. Patients will be randomly assigned to the real-time heart team group and the conventional heart team group by block randomization. The real-time heart team group needs to conduct multidisciplinary heart team discussion during the coronary angiography process, while the traditional heart team group needs to conduct multidisciplinary heart team discussion offline and face-to-face after the coronary angiography process. This study will prospectively collect the patient information, heart team meeting process, clinical treatment, and clinical outcomes to evaluate the efficiency and feasibility and differences in clinical outcomes of patients under different heart team approaches.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| real-time heart team group | Experimental | Patients randomized to this group will be accessed and discussed by multidisciplinary specialists during the coronary angiography process |
|
| conventional heart team group | Active Comparator | Patients randomized to this group will be accessed and discussed offline and face-to-face by multidisciplinary specialists after the coronary angiography process |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| heart team meeting and discussion | Behavioral | When the patient is eligible for the study, the interventional cardiologist will invite a cardiac surgeon to conduct a heart team discussion. Both specialists will assess the patient comprehensively and make an optimal decision for the patient, with consideration patient's preference. |
| Measure | Description | Time Frame |
|---|---|---|
| 1-year major adverse cardiovascular and cerebrovascular events | a composite of all-cause mortality, myocardial infarction, stroke, unplanned revascularization, readmission due to reangina. | At 1 year after the coronary angiography |
| Measure | Description | Time Frame |
|---|---|---|
| time interval between the completion of coronary angiography and the final treatment | time interval is considered as a key secondary outcome | through treatment completion, an average of 60 days |
| revascularization decision-making |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Zhe Zheng, MD,PhD | Chinese Academy of Medical Sciences, Fuwai Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| China National Center for Cardiovascular Diseases | Beijing | Beijing Municipality | 100037 | China |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41778947 | Derived | Lin S, Su X, Ma H, Dou K, Song L, Zhao H, Qian J, Liu S, Xu F, Wang X, Yang Y, Su P, Jin Z, Wang Y, Zheng Z. Real-Time Heart Team for Revascularization in Complex Coronary Artery Disease: The EHEART Randomized Trial. J Am Coll Cardiol. 2026 Jun 23;87(24):3467-3479. doi: 10.1016/j.jacc.2026.01.010. Epub 2026 Mar 4. | |
| 37989362 | Derived |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002318 | Cardiovascular Diseases |
| D003324 | Coronary Artery Disease |
| ID | Term |
|---|---|
| D003327 | Coronary Disease |
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D001161 | Arteriosclerosis |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
to assess the distribution of the revascularization decision-making made jointly by the heart team and the patients, such as CABG, PCI or medical therapy
| through study completion, an average of 1 year |
| revascularization decision-making guideline adherence | adjudicated according to 2018 European Society of Cardiology (ESC)/ European Association for Cardio-Thoracic Surgery (EACTS) guideline | through study completion, an average of 1 year |
| heart team decision-making | to assess the distribution of the decision-making made by the heart team, such as CABG, PCI or medical therapy | through study completion, an average of 1 year |
| workload of heart team specialists | to assess the workload of the specialists participating in the heart team meetings by NASA-TLX scale | through study completion, an average of 1 year |
| success rate of heart team organization | to assess the successful-connection with cardiac surgeons during or after the coronary angiography | through study completion, an average of 1 year |
| length of stay | to assess length of stay (LOS) before the final treatment, and the totol LOS in hospital | through study completion, an average of 1 year |
| total cost | to assess the total cost in hospital for the initial hospitalization and rehospitalization | through study completion, an average of 3 year |
| individual clinical adverse events | including all-cause death, cardiac death, myocardial infarction, stroke, revascularization of target vessels or transplanted vessels, revascularization for any reason, be admitted to hospital with angina again, readmission for cardiac reasons and readmission for any reason | At 1 year after the coronary angiography |
| Su X, Ma H, Lin S, Dou K, Zheng Z. Safety and feasibility of a real-time electronic heart team decision-making approach in patients with complex coronary artery disease: a protocol for a randomised controlled trial (EHEART trial). BMJ Open. 2023 Nov 21;13(11):e076864. doi: 10.1136/bmjopen-2023-076864. |
| D001157 |
| Arterial Occlusive Diseases |
| D014652 | Vascular Diseases |